Agathe Richard is an associate in the Litigation Department. Agathe’s focus includes U.S. antitrust law and European competition law (merger control investigations, restrictive arrangements and monopolization cases).
Agathe advised on the following significant matters:
- Teva Pharmaceuticals in the Perindopril and Modafinil antitrust investigations by the European Commission
- Teva Pharmaceuticals in its $6.8 billion acquisition of Cephalon
- Teva Pharmaceuticals in its $5 billion acquisition of Ratiopharm GmbH
- Gaz de France in its merger with Suez